Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model

In this paper, we have investigated sustained release biodegradable nanospheres for the delivery of plasmid DNA. The nanospheres were formulated using a proprietary co-polymer emulsion technique to encapsulate plasmid DNA. Gene transfection with nanospheres containing reporter genes (human placental alkaline phosphatase (AP) or Luciferase) was demonstrated in tissue culture (293T and COS-7 cells), and also in vivo in a nonunion femoral fracture (osteotomy) rat model. The bone gap was filled with nanospheres and gene expression in the implantation site was measured five weeks after the initial surgery. The nanospheres had a mean diameter of 230 nm, with a DNA loading of 0.7%w/w. These nanospheres demonstrated sustained release of the encapsulated DNA under in vitro physiologic conditions with an 82% cumulative DNA release over 17 days. The transfection efficiency of the nanospheres in tissue culture was two to five orders of magnitude greater than the gene expression with the same amount of plasmid DNA in solution. In the rat studies, the mean AP activity in the tissue retrieved from the osteotomy site in the experimental group was 291.8±52.5 cpm Versus 54.1±26.5 cpm (mean±S.E.M., P=0.03) in the sham control group. In conclusion, plasmid DNA nanospheres could be used as an effective nonviral method of gene delivery. In the future, nanospheres containing therapeutic genes, such as those encoding parathyroid hormone peptide, 1–34 amino acids (PTH-34) or Bone Morphogenic Protein-4 (BMP-4), could be used for the healing of nonunion bone fracture sites.